Latest news
Loading news…
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases, with late-stage development
Durect was acquired by Bausch Health in 2025 for $63M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
1
Monthly Visits
Available in Pro Contacts
76
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Cupertino, California, United States
Acquisitions by Durect
Loading columns…
0 of 0Show
Page 1 / 1
Key People at Durect
Co-Founder ,President & Chief Executive Officer
VP Regulatory Affairs
76
professional contacts at Durect
Contact execs at Durect →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Durect
Loading news…
FAQs about Durect
People who checked this page also checked these
Sectors Durect invests & acquires in
Browse the full Acquirezy directory.